CN Patent

CN103550159B — 盐酸苯达莫司汀固体形式

Assigned to Safran SA · Expires 2016-02-10 · 10y expired

What this patent protects

本文描述了盐酸苯达莫司汀固体形式。本发明涉及含苯达莫司汀的组合物、包括苯达莫司汀的药物组合物、可重复制备它们的方法、以及使用它们来治疗患者的方法。

USPTO Abstract

本文描述了盐酸苯达莫司汀固体形式。本发明涉及含苯达莫司汀的组合物、包括苯达莫司汀的药物组合物、可重复制备它们的方法、以及使用它们来治疗患者的方法。

Drugs covered by this patent

bendamustine-hydrochloride (BENDAMUSTINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN103550159B
Jurisdiction: CN
Classification: —
Expires: 2016-02-10
Drug substance claim: No
Drug product claim: No
Assignee: Safran SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.